Bioxcel therapeutics announces formation of onkosxcel therapeutics to develop medicines focused in oncology

Onkosxcel, a company subsidiary, to utilize proprietary ai-powered platform to progress therapies to address difficult-to-treat cancers with high unmet need

BTAI Ratings Summary

BTAI Quant Ranking